Navigation Links
Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
Date:6/26/2009

SEATTLE, June 26 /PRNewswire/ -- The Fred Hutchinson Cancer Research Center board of trustees today announced that its president and director, Lee Hartwell, Ph.D., plans to retire in June 2010. Hartwell, a recipient of the 2001 Nobel Prize in physiology or medicine, has been president and director of the Hutchinson Center since 1997.

"It's time," Hartwell said. "I have been president and director of the Center for 12 years. It's time for new leadership." Hartwell, who will turn 70 in October, says he informed the board's executive committee more than a year ago of his desire to retire and to begin the transition to new leadership. The exact timing of his departure was worked out over the last few months. The full board, faculty and staff were notified during the past two days.

Today's announcement was made by Doug Walker, chair of the Center's board of trustees, who said the search for Hartwell's successor will begin immediately. "Lee's leadership over these last 12 years has been extraordinary," Walker said. "It's hard for us to picture Fred Hutchinson Cancer Research Center without Lee at the helm. We're fortunate that Lee will be around to ensure that the transition to new leadership will be an extremely smooth one."

Walker says a search committee has been selected and it, in turn, will select a consultant to assist with the search. Board member Steve Davis, a senior adviser at McKinsey & Company, will head the search committee, which will also include members of the board and scientific faculty.

"The first thing we need to do is make a thorough assessment of the position and discuss the qualifications for the next Center leader with the Center's scientific faculty as well as community leadership," Walker said. "We'll use this information to determine the qualities and qualifications of the person we hope to recruit. Walker says there is no specific time frame attached to the search. "It will conclude when we have the best candidate for the position," he said.

After Hartwell retires in 2010, he hardly will be idle. He will continue to be involved with the Center as director emeritus and also will continue his work in early cancer detection and science education. He will also continue his role as chairman of the executive committee of the Partnership for Personalized Medicine, an Arizona-based global effort to improve patient outcomes and reduce health care costs.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

    CONTACT:
    Kristen Woodward
    206-667-5095
    kwoodwar@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
2. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
3. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
4. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
5. Graphene pioneers follow in Nobel footsteps
6. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
7. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
8. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
9. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
10. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
11. Laureate Announces Manufacturing Agreement with Tolerx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , ... May 02, 2016 , ... ... its clients in mind, the fresh look and added functionality give the agricultural ... years have seen a dynamic shift in agriculture – from precision farming via ...
(Date:4/29/2016)... , ... April 30, 2016 , ... The MIT bioLogic ... design, the bioLogic team explored how bacterial properties can be applied to fabric and ... Natto bacteria, which move in response to humidity change. The team harvested Natto cells ...
(Date:4/29/2016)... , April 29, 2016 ... Transparency Market Research "Separation Systems for Commercial Biotechnology ... Trends, and Forecast 2015 - 2023", the separation ... US$ 10,665.5 Mn in 2014 and is projected ... 2015 to 2023 to reach US$ 19,227.8 Mn ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intelligent Implant Systems announced today that the two-level ... sale in the United States. These components expand the capabilities of the system ... sales beginning in October of 2015, the company has seen significant sales growth in ...
Breaking Biology Technology:
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
(Date:3/8/2016)... , March 8, 2016   Valencell ... technology, today announced it has secured $11M in ... GII Tech, a new venture fund being launched ... additional participation from existing investors TDF Ventures and ... funds to continue its triple-digit growth and accelerate ...
(Date:3/3/2016)... England and DE SOTO, Kansas ... , U.S.-based Stroke Detection Plus® to offer Oncimmune,s ... risk assessment and early detection of lung cancer ... large employers, unions and individuals. --> Early ... unions and individuals. --> Oncimmune, a leader ...
Breaking Biology News(10 mins):